Anthropic reportedly to plan IPO investor meetings in coming weeks
Newsquawk Staff ·
Anthropic reportedly to plan IPO investor meetings in coming weeks.
- American Express (AXP) Q3 2026 (USD): EPS 5.42 (exp. 4.50), Revenue 20.1bln (exp. 20.1bln)
- Booz Allen (BAH) Q2 2026 (USD): Adj. EPS 1.76 (exp. 1.48), Revenue 2.80bln (prev. 2.81bln)
- SLB (SLB) Q3 2026 (USD): adj. EPS 0.64 (exp. 0.62), Revenue 9.45bln (exp. 9.27bln)
- Citi (C) has been granted approval by China for its securities unit
- Newsquawk Daily US Equity Opening News - TSLA & META fall after earnings; TSLA & SPCX said to target H1 2027 merger
Related headlines
- Tesla (TSLA) has decided not to proceed with plans to produce Cybertruck for Australia and New Zealand11 hours ago
- OpenAI trims valuation target to USD 1.25tln after previously pitching a higher price, according to FT13 hours ago
- Newmont (NEM) says production growth is expected to begin in 2027 following previously flagged 2026 trough, adds Q3 gold production was broadly flat sequentially as anticipated13 hours ago
- SpaceX (SPCX) in talks to access 80,000 cell sites for new network13 hours ago
- Google (GOOG) announces general availability of an Anthropic-managed deployment option for Claude models on Google Cloud14 hours ago
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE15 hours ago
- Gilead Sciences (GILD) entered into a definitive agreement to acquire an oral IL-23R inhibitor program, including lead asset HCXT-2001, from PepStar Therapeutics Limited; deal valued at USD 1.27bln in upfront cash15 hours ago
- Newmont (NEM) Q3 2026 (USD): Adj. EPS 2.20 (exp. 2.06), Revenue 6.36bln (exp. 6.30bln), Adj. EBITDA 3.95bln (exp. 3.73bln)15 hours ago
- Bloom Energy (BE) Q3 2026 (USD): Adj. EPS 0.94 (exp. 0.69), Revenue 1.24bln (exp. 1.06bln)15 hours ago
- Western Digital (WDC) Q1 2027 (USD): Adj. EPS 4.64 (exp. 4.08), Revenue 4.38bln (exp. 4.14bln)15 hours ago
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone16 hours ago
- DataDog (DDOG) recently offered almost USD 4bln to acquire Upwind Security, but the Co. hasn't accepted the offer, reports The Information citing sources17 hours ago
- Statnews posts on X, "Rumors are swirling that the Treasury Department this week is going to propose a rule that restricts U.S. investment in the Chinese biotech sector"18 hours ago
- Moderna (MRNA) downside attributed to early data leaks (link below) - UNCONFIRMED18 hours ago
- State of Rhode Island sues Meta (META) over alleged tolerance for scam advertising19 hours ago